Fig. 1From: The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseasesTypologies of cancer developed in the 474 study patients and the time of cancer diagnosis from the diagnosis of chronic inflammatory rheumatic disease and from enrollment. Malignancies traditionally associated with metabolic syndrome (MetS) are ringed by gray shadowsBack to article page